What is a healthy waist-to-hip ratio?

Research commonly uses WHR above 0.90 for men and above 0.85 for women as thresholds for central obesity. However, these are population-level reference values, not personal targets. Your ExomeDNA result reflects your genetic predisposition to fat distribution pattern, not a clinical cutoff.

Does WHR adjusted for BMI mean my weight is factored out?

Yes. WHR adjusted for BMI isolates the genetics of where fat is stored from the genetics of how much fat is carried overall. Two people with identical BMI can have very different WHR values, and this GWAS identified variants that explain part of that difference.

Can exercise change my waist-to-hip ratio?

Yes. Aerobic exercise and resistance training both preferentially reduce visceral fat, which lowers WHR more than they reduce subcutaneous fat. The GWAS underlying this trait (Graff et al. 2017, PMID 28448500) was specifically designed to study gene-by-physical-activity interactions in WHR.

Why do women tend to have lower WHR than men?

Estrogen promotes gluteofemoral fat storage in hips and thighs, producing a lower WHR on average in premenopausal women. After menopause, estrogen decline shifts fat distribution toward the abdomen, raising WHR and narrowing the sex difference.

What does a high WHR genetic result mean for me?

A higher genetic score for WHR indicates that your inherited biology predisposes your fat distribution set point toward a relatively higher waist-to-hip ratio. This is a predisposition, not a destiny. Physical activity and diet quality have well-documented effects on visceral fat accumulation independent of genetic starting point.

Which genes are most strongly associated with WHR in this study?

Among the authorized genes for this trait, ABCA1 ranks highest by locus-to-gene confidence score (0.90), followed by ADAMTS9 (0.86). Additional genes include ANKRD55, ARHGEF28, BAZ1B, BTNL2, and CALCRL, representing cholesterol transport, ECM remodeling, cytoskeletal signaling, chromatin programming, immune regulation, and vascular biology.

Waist-to-Hip Ratio and Your Exercise Response

Authored by the ExomeDNA Science Team. This page contains general information only. For personal health decisions, consult a qualified clinician.

Waist-to-hip ratio (WHR) is a measure of how fat is distributed across your body, capturing whether weight accumulates preferentially around your midsection or your hips and thighs. A 2017 genome-wide meta-analysis (PMID 28448500, Graff et al.) identified multiple genetic loci that influence WHR independently of total body mass, implicating genes involved in cholesterol transport, extracellular matrix remodeling, immune signaling, and adipose vascular biology. Below: the genetics of fat distribution, what the research says, and evidence-based actions tied to your result.

What is waist-to-hip ratio?

Waist-to-hip ratio is calculated by dividing waist circumference by hip circumference. A measurement at the navel divided by the widest point around the buttocks yields a single number that captures body shape more precisely than scale weight alone.

Where fat is stored matters as much as how much fat you carry. Visceral fat, packed around internal organs in the abdomen, is metabolically active in ways that subcutaneous fat stored under the skin at the hips and thighs is not. Visceral fat releases fatty acids directly into the portal bloodstream, elevates circulating inflammatory markers, and impairs insulin signaling. Gluteofemoral fat, by contrast, acts as a metabolic buffer, sequestering triglycerides and releasing beneficial adipokines.

The conventional research cutoffs: WHR above 0.90 for men and above 0.85 for women is classified by the World Health Organization as indicating central obesity. Your ExomeDNA result reflects a genetic predisposition to where on the WHR distribution your body-shape set point tends to fall, not a fixed outcome.

WHR adjusted for BMI, the specific measure studied in the GWAS underlying this trait, isolates the genetics of fat distribution from the genetics of total fat mass. Two people can share the same BMI yet have strikingly different WHR values, and a portion of that difference is encoded in their DNA.

The genetics behind waist-to-hip ratio

The 2017 genome-wide physical activity interaction study (Graff et al., PMID 28448500) was a large meta-analysis examining genetic loci for WHR adjusted for BMI, with a specific focus on how those genetic effects are modified by physical activity levels. The study identified loci across multiple chromosomes, with genes playing distinct biological roles in fat distribution.

Among the authorized genes implicated in this trait, ABCA1 (ATP-binding cassette transporter A1) is a cholesterol efflux transporter expressed in adipocytes. In fat cells, ABCA1 exports excess cholesterol from the cell membrane, regulating lipid raft composition, insulin receptor function, and adipokine secretion. Variants in ABCA1 may alter how visceral and subcutaneous adipocytes handle intracellular cholesterol, contributing to depot-specific differences in fat accumulation. The gene ranks second by locus-to-gene score in this trait with a high-confidence score of 0.90.

ADAMTS9 encodes a secreted metalloprotease that remodels the extracellular matrix of adipose tissue. ECM composition determines the mechanical properties of fat depots, governs preadipocyte differentiation, and constrains adipocyte expansion. Variants in ADAMTS9 appear across both total waist circumference and WHR genome-wide studies, reflecting its broad role in adipose ECM biology. Its locus-to-gene score is 0.86, ranked fourth.

ANKRD55 (ankyrin repeat domain 55) is expressed in immune cells and has been associated with inflammatory conditions including multiple sclerosis, type 2 diabetes, and rheumatoid arthritis in prior genome-wide studies. Its presence in the WHR signal points to adipose tissue immune dynamics: macrophage infiltration of visceral adipose tissue drives a chronic low-grade inflammatory state that promotes further visceral expansion and insulin resistance.

ARHGEF28 activates RhoA GTPase signaling. In preadipocytes, the RhoA/ROCK pathway regulates cytoskeletal tension and influences the balance between adipogenic and alternative cell fates. Visceral and subcutaneous preadipocytes differ in their baseline Rho signaling activity, and genetic variants in ARHGEF28 may subtly shift depot-specific adipogenic potential.

BAZ1B is a chromatin remodeling factor located in the Williams-Beuren syndrome critical region on chromosome 7. Chromatin accessibility programs are a key determinant of depot identity in adipose tissue: the genes switched on or off during preadipocyte differentiation differ between visceral and subcutaneous depots, and BAZ1B variants may influence those depot-specific epigenetic landscapes.

BTNL2 (butyrophilin-like protein 2) is an immune checkpoint molecule encoded within the MHC class III region. It is expressed on T lymphocytes and macrophages and inhibits T cell activation. In adipose tissue, BTNL2 contributes to the immune microenvironment regulation that governs adipose tissue inflammation, a key mediator of the link between visceral fat and systemic metabolic effects.

CALCRL encodes the calcitonin receptor-like receptor, a G protein-coupled receptor that binds calcitonin gene-related peptide and adrenomedullin. CALCRL is highly expressed in the adipose vasculature, where calcitonin gene-related peptide acts as a potent vasodilator. Adipose blood flow regulation differs markedly between visceral and subcutaneous depots, and this vascular difference affects nutrient delivery, lipolysis, and fat distribution set points.

What the research says

Research base: Moderate. The GWAS underlying this trait (Graff et al. 2017, PMID 28448500) is notable for its focus on gene-by-physical-activity interaction effects. The study analyzed data across multiple large cohorts and tested whether the genetic contribution to WHR is modified by how physically active a person is. This design allowed researchers to identify both main-effect loci (variants that influence WHR regardless of activity) and interaction loci (variants whose effect on WHR is amplified or attenuated by physical activity behavior).

Key findings from the research base include the following. Physical activity specifically and disproportionately reduces visceral fat accumulation relative to subcutaneous fat, making WHR a sensitive indicator of exercise response. The genetic architecture of WHR adjusted for BMI is partly distinct from that of BMI itself, supporting the biological separation of fat distribution from total fat mass. Sex differences in WHR genetics are substantial: women carry a higher proportion of gluteofemoral fat on average, and the hormonal shift at menopause drives redistribution toward higher WHR, narrowing this sex difference in older age. The loci identified span genes in cholesterol metabolism (ABCA1), ECM remodeling (ADAMTS9), immune regulation (ANKRD55, BTNL2), cytoskeletal signaling (ARHGEF28), chromatin programming (BAZ1B), and vascular biology (CALCRL), indicating that WHR is governed by the coordinated biology of adipose tissue architecture, immune infiltration, and vascular supply.

The confidence tier for this trait is moderate, reflecting a robust discovery study with biological plausibility across implicated genes, and recognizing that the majority of WHR variation remains explained by non-genetic factors including diet, physical activity, hormonal status, and age.

How waist-to-hip ratio affects you

WHR is one of the most informative single-number summaries of metabolic body composition. A higher WHR, reflecting more apple-shaped fat distribution, is associated with elevated cardiometabolic risk. A lower WHR, reflecting more pear-shaped distribution, is associated with relative metabolic protection driven largely by the distinct biology of gluteofemoral fat.

The ExomeDNA WHR result captures genetic predisposition to fat distribution pattern, adjusted for total body mass. A result indicating higher genetic WHR tendency does not mean that outcome is fixed. Because physical activity specifically reduces visceral fat accumulation, and because the underlying GWAS was designed to study gene-by-activity interactions, this is a trait where lifestyle inputs directly engage the genetic mechanism.

Hormonal context matters: women naturally carry protective gluteofemoral fat during the reproductive years. The post-menopausal decline in estrogen accelerates visceral fat redistribution. Men carry higher visceral fat loads at equivalent total adiposity from earlier in life. Knowing your genetic baseline helps contextualize your trajectory, particularly around hormonal transitions.

Waist and hip circumference are inexpensive, non-invasive tracking metrics. Measuring at consistent anatomical landmarks and tracking WHR over months captures whether lifestyle changes are selectively reducing visceral accumulation, even when scale weight changes little.

Working with your waist-to-hip ratio result

Actions supported by evidence for influencing WHR, ordered by strength of evidence:

Resistance training. Skeletal muscle is the largest metabolic tissue in the body. Building and maintaining muscle mass increases resting glucose disposal, reduces visceral fat preferentially, and lowers WHR independent of total weight change. Two to three sessions per week of compound movements is the foundation.
Aerobic exercise, especially higher-intensity intervals. Vigorous cardio drives a disproportionate reduction in visceral fat relative to subcutaneous fat. This is the biological mechanism the Graff et al. study was designed to examine. Consistency over months is required to see WHR change.
Mediterranean or whole-food dietary pattern. Emphasis on vegetables, legumes, fish, olive oil, and limited ultra-processed foods reduces circulating triglycerides and inflammatory markers associated with visceral adipose expansion.
Cortisol and stress management. Cortisol is the primary driver of visceral fat deposition via direct glucocorticoid receptor activation in visceral preadipocytes. Chronic stress, sleep deprivation, and HPA axis dysregulation elevate cortisol and selectively promote abdominal fat accumulation. Sleep quality is a first-line intervention.
Hormonal awareness. Estrogen declines at menopause drive visceral redistribution in women. Discuss this trajectory with a clinician, particularly if WHR is changing despite stable lifestyle practices.
Avoid prolonged sedentary bouts. Even in regular exercisers, extended sitting interrupts lipoprotein lipase activity and promotes lipid uptake into visceral depots. Breaking up sedentary time every 30 to 60 minutes has measurable metabolic benefit.

Monitor waist and hip circumference monthly under consistent conditions. Track WHR over time rather than absolute measurements to capture distribution change independent of weight fluctuation.

Waist-to-hip ratio captures fat distribution, which intersects with several related traits covered elsewhere on ExomeDNA. Total waist circumference is a closely related but distinct measurement that reflects absolute abdominal size rather than the ratio between depots. Body mass index genetics overlap partially but reflect total fat mass accumulation rather than distribution. Metabolic traits including triglyceride levels, HDL cholesterol, and fasting glucose are downstream consequences of visceral fat biology and share partial genetic architecture with WHR. Cardiorespiratory fitness influences visceral fat independently and interacts with WHR genetics, as documented in the Graff et al. study design. The ABCA1 gene, which ranks as a top locus in this trait, is also a central gene in HDL cholesterol metabolism and LDL particle biology.

Frequently asked questions

See FAQ section below.

ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.

--- References: Graff M et al. (2017). Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults. PMID 28448500.

Browse all traits →